Capiton AG has successfully transitioned its investment in Dec Group to capiton VI, facilitating the company’s growth strategy and securing a partnership with financial investor ICG.
Target Information
Dec Group is a renowned global leader in high-containment processing technologies serving the pharmaceutical, chemical, and specialty industries. The company has undergone significant transformation and growth since capiton V's initial investment in 2020. With a commitment to providing comprehensive end-to-end solutions, Dec Group has successfully strengthened its market position through strategic acquisitions and an expanded product and technology portfolio, ultimately enhancing its value proposition.
Under capiton's stewardship, Dec Group evolved into a more competitive player in its sector, demonstrating remarkable resilience and adaptability. This transformation has not only positioned Dec to meet the existing demands of its industries but also to anticipate and capitalize on future trends, further solidifying its reputation as a trusted partner for blue-chip clients across more than 60 countries.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview
The high-containment processing technology industry is experiencing significant growth, particularly as demand increases for advanced pharmaceutical and chemical solutions worldwide. Driven by r
Similar Deals
MDG Molecular Diagnostics Group GmbH → oncgnostics GmbH
2025
SHS Capital → Ackermann Instrumente GmbH
2025
Serafin Unternehmensgruppe → Gross GmbH
2025
capiton VI
invested in
Dec Group
in 2025
in a Other Private Equity deal